Impact of COVID-19 on Antimicrobial Use and Antimicrobial Resistance
- Funded by University of Minnesota
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
University of MinnesotaPrincipal Investigator
DVM. Randall SingerResearch Location
United States of AmericaLead Research Institution
College of Veterinary Medicine, University of MinnesotaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Environmental stability of pathogen
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Led by Randall Singer, DVM, PhD, professor of epidemiology, College of Veterinary Medicine, and co-leads Irene Bueno, DVM, MPH, PhD, and Bill Arnold, PhD, researchers in this study will conduct environmental sampling of water to quantify antimicrobial concentrations and antimicrobial resistant bacteria that are relevant to human health. They will also obtain antibiotic use data at the major Minnesota hospitals and correlate these data with the environmental sampling results. "Antimicrobials are not entirely metabolized by humans after administration, and wastewater treatment plants cannot completely remove antimicrobials during the treatment process. In addition, antimicrobial resistant bacteria may also survive and even be concentrated by wastewater treatment," said Singer. "Thus, the natural environment can serve as a proxy of antimicrobial usage and antimicrobial resistance changes in the human population."